Identification
Symbol
ALEMG
ISIN code
FR0000075343
Exchange / Market
Euronext Growth
Trading location
Paris
ICB
20102015 Medical Supplies
Operation
IPO date
IPO type
Direct listing
Transfer
Transfer details
Euronext - Euronext Growth

Company profile

Euromedis Groupe specializes in the design, manufacturing and distribution of medical equipment intended primarily for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. Net sales break down by activity as follows:
  • design and manufacturing of medical equipment (68%): gloves (No. 1 in France in disposable medical gloves), surgical items (sensors, pockets, scalpels, etc.), hygiene and protection equipment (white-coats, masks, shoes, etc.), parenteral approaches (needles, syringes, transfusion equipment, etc.), and other (compresses, bandages, beds, etc.) marketed under the company's brand name (Euromedis);
  • distribution of medical-surgical equipment (32%): operates through a network of outlets under the Paramat name. The group also leases equipment and provides home maintenance and hospitalization services.

Source: Cofisem - Last Update: 22 Oct 2020
Key Executives
Chairman and Chief Executive Officer Mathieu Roturier
Source: Cofisem - Last Update: 19 Jun 2020
Key figures
Millenium 2019 2018 2017 2016 2015
Net sales 77.080 107.980 73.603 73.166 71.195
Income from ordinary activities 77.080 107.980 73.603 73.166 71.195
Operating income -2.760 -8.766 -244 1.292 3.348
Cost of financial indebtedness net -363 -490 -272 -240 -348
Equity-accounted companies contribution to income 144 162 155 141 142
Net profit from discontinued activities 127
Net income -3.796 -6.920 -134 1.016 2.473
Net income (Group share) -3.799 -6.970 -146 1.007 2.473
Fiscal year end 12,19 12,18 7,17 7,16 7,15
Length of fiscal year (month) 17 17 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 22 Oct 2020
Shareholder information
Nina 66,47 %
Roturier 10,03 %
IDIA 5,24 %
Group-owned stock 0,90 %
Source: Cofisem - Last Update: 22 Oct 2020